InVivo Therapeutics (NSDQ:NVIV) said today it is looking to ‘Bioengineered Neural Trails’, injectable biomaterial and neural stem mixtures, to help treat chronic spinal cord injuries. The Cambridge, Mass.-based company said it will focus its research efforts on the new therapy, and has inked agreements with the University of California, UC San Diego and Dr. James Guest […]
Research & Development
Xenios expands manufacturing, R&D footprint
Xenios said today it expanded its research & development and manufacturing operations to include a new combined facility. The Reutlingen, Germany R&D and manufacturing facility was added as the company continues on what it calls an “aggressive growth strategy.” “Given that no other company except Xenios is offering minimally invasive lung and heart therapies on 1 platform, and given that […]
New from the biotech store: an improved gene editing tool
(Reuters) – Scientists have developed an improved gene editing tool that significantly reduces potentially dangerous “off-target” edits, promising an even more precise and efficient system for manipulating human DNA. Editing the genes of living organisms, including humans, holds out great promise for treating diseases. But it could also be used to create “designer babies”, prompting […]
Propeller Health, GlaxoSmithKline sign R&D deal for dry powder inhaler
Propeller Health said today it inked a deal with GlaxoSmithKline (NYSE:GSK) to develop a sensor for GSK’s Ellipta dry powder inhaler. Through the non-exclusive agreement, the 1st between the 2 companies, Propeller will develop and manufacture a custom sensor for the Ellipta inhaler for use in clinical studies of the device used to treat asthma and […]
Debiotech, Fresenius partner to develop home dialysis tech
Swiss med device firm Debiotech and dialysis device developer Fresenius Medical said today they are partnering to develop home-usable peritoneal dialysis technologies. The companies said they aim to create a platform of dialysis machines that are lightweight and compact to allow patients to travel with the device and use them at home. The newly partnered […]
Flowonix, Cerebral Therapeutics ink deal to dev direct-to-brain drug delivery system
Flowonix Medical and Cerebral Therapeutics said today they signed a deal to develop an implanted brain-targeted drug delivery system to treat neurological diseases. The device is being designed to deliver microdoses of medication directly to the brain, bypassing the blood-brain barrier and reaching specifically targeted regions for more effective dosing, Mount Olive, N.J.-based Flowonix said. “Neurological […]
Bovie snatches up Bulgarian R&D and manufacturing contractor
Bovie Medical (NYSE:BVX) said yesterday it bought its Bulgarian R&D and manufacturing contractor for $570,000 (EU€500,000). The deal was made for cash over a 5-year period, with an initial payment of $427,000 (EU€375,000) made at closing, and a remaining payment of $143,000 (EU€125,000) due in October, 2020, the Clearwater, Fla.-based company said. “We are pleased to […]
Johns Hopkins launches epilepsy study using Apple Watch
Johns Hopkins University said yesterday it is launching the EpiWatch patient data collection app for Apple‘s (NSDQ:AAPL) Apple Watch to collect data for patients with epilepsy before, during and after seizures. Data from the app will be used to analyze and better understand epilepsy, and to develop new methods for monitoring and managing the disease, […]
Corindus Vascular, Mayo Clinic sign robotic PCI research deal
Corindus Vascular Robotics (OTC:CVRS) said today it signed a deal with the Mayo Clinic to form a joint robotic-assisted percutaneous coronary intervention research and clinical program. The program will use Corindus’ CorPath robotic-assistance system designed for coronary PCI procedures. The system allows operating physicians to avoid radiation exposure and orthopedic strain from wearing lead protective vestments […]
Medtronic participates in $6.8m Mayo Clinic epilepsy project
Medtronic (NYSE:MDT) will be joining the Mayo Clinic in a new $6.8 million National Institutes of Health funded project to develop intelligent devices to track and treat abnormal brain activity in epilepsy patients. The funds come from a 5-year federal grant from the NIH as part of a presidential initiative aimed at better understanding and researching the […]
NICO & Hitachi collab on ultrasound brain probe
Neurological device maker NICO and Hitachi (NYSE:HIT) said they are collaborating to create an ultrasound probe to aid in brain tumor operations using Nico’s BrainPath device. Hitachi’s Aloka ultrasound probe, which is still being developed, will be usable with Nico’s BrainPath device to allow operators better visualization of the location, size, and proximity of vessels during […]